Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsIndia

COVID-19 vaccination of half of Indian population is key to economic revival: NITI Aayog

Individuals aged 18 and above will be eligible for COVID-19 vaccination from May 1.

April 30, 2021 / 08:46 AM IST
An old woman waits for her turn to receive COVID-19 vaccine in Mumbai, (Image: AP)

An old woman waits for her turn to receive COVID-19 vaccine in Mumbai, (Image: AP)

COVID-19 vaccination of at least half the population in India is key for revival of the economy, NITI Aayog Vice Chairman Rajiv Kumar said.

"We have the capability of vaccinating them in the next few months," Kumar was quoted as saying by The Times of India.

If the economy grows at 10-11 percent per year for the next few decades, the per capita income can be $16,000 by 2050, Kumar said at a webinar organised by industry body MCCI.

He listed five conditions for India to achieve this growth rate:

> India should increase its rate of investment from below 30 percent of Gross Domestic Product (GDP) to 35-40 percent of GDP.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

> India must raise the share of exports in GDP

> Share of manufacturing in GDP must increase

> Modernisation of agriculture

> The government will continue to remove regulatory hurdles for ease of doing business, and the private sector must demonstrate self-regulation to evolve as a responsible growth partner.

In India, healthcare workers, frontline workers and individuals aged 45 and above are currently eligible for vaccination. Everyone aged 18 and above will be eligible for vaccination from May 1.

As of 7 am on April 29, 2.58 crore beneficiaries have taken their second shots of COVID-19 vaccines since the drive began, according to Union health ministry data.
Moneycontrol News
first published: Apr 30, 2021 08:46 am

stay updated

Get Daily News on your Browser
Sections